- Malaysia
- /
- Healthcare Services
- /
- KLSE:IHH
IHH Healthcare Berhad Full Year 2024 Earnings: Beats Expectations
IHH Healthcare Berhad (KLSE:IHH) Full Year 2024 Results
Key Financial Results
- Revenue: RM25.1b (up 20% from FY 2023).
- Net income: RM2.66b (down 10.0% from FY 2023).
- Profit margin: 11% (down from 14% in FY 2023). The decrease in margin was driven by higher expenses.
- EPS: RM0.30 (down from RM0.34 in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
IHH Healthcare Berhad Revenues and Earnings Beat Expectations
Revenue exceeded analyst estimates by 4.6%. Earnings per share (EPS) also surpassed analyst estimates by 32%.
Looking ahead, revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the Healthcare industry in Malaysia.
Performance of the Malaysian Healthcare industry.
The company's shares are up 2.6% from a week ago.
Balance Sheet Analysis
While earnings are important, another area to consider is the balance sheet. We have a graphic representation of IHH Healthcare Berhad's balance sheet and an in-depth analysis of the company's financial position.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About KLSE:IHH
IHH Healthcare Berhad
An investment holding company, offers healthcare services in Malaysia, Singapore, Turkey, India, China, Japan, Europe, and internationally.
Mediocre balance sheet and slightly overvalued.
Similar Companies
Market Insights
Weekly Picks

Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share

EU#4 - Turning Heritage into the World’s Strongest Luxury Empire

The "Easy Money" Is Gone: Why Alphabet Is Now a "Show Me" Story
Recently Updated Narratives

BIPC: A strategic player in the energy crisis, a hybrid of Utility and Digital REIT.

Quintessential serial acquirer

EU#1 - From German Startup to EU’s Biggest Company
Popular Narratives
Undervalued Key Player in Magnets/Rare Earth

Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share

The "Sleeping Giant" Stumbles, Then Wakes Up
Trending Discussion
As a gamer, I would not touch this company now. They are hated by the community and have been releasing major flops on their AAA games during the last 5 years (for good reasons). It is true that the valuation is ridiculously low compared to what the licenses are worth, but if the trend continues the value of those will also decline. Management needs to almost make a 180° turnaround to get things right. I agree that a take-private deal before it is too late might be the best option for an investor entering today. We might also see a split sales of the different studios. It is a very risky play, but potentially with high reward.
